These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38923004)

  • 1. Tumor-associated macrophages: The key player in hepatoblastoma microenvironment and the promising therapeutic target.
    Adawy A; Komohara Y; Hibi T
    Microbiol Immunol; 2024 Aug; 68(8):249-253. PubMed ID: 38923004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma.
    Park DJ; Sung PS; Lee GW; Cho S; Kim SM; Kang BY; Hur W; Yang H; Lee SK; Lee SH; Jung ES; Seo CH; Ahn J; Choi HJ; You YK; Jang JW; Bae SH; Choi JY; Yoon SK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages as Targets in Hepatocellular Carcinoma Therapy.
    Liu YT; Mao ZW; Ding Y; Wang WL
    Mol Cancer Ther; 2024 Jun; 23(6):780-790. PubMed ID: 38310642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire.
    Malik S; Sureka N; Ahuja S; Aden D; Zaheer S; Zaheer S
    Cell Biol Int; 2024 Oct; 48(10):1406-1449. PubMed ID: 39054741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review).
    Yu M; Yu H; Wang H; Xu X; Sun Z; Chen W; Yu M; Liu C; Jiang M; Zhang X
    Int J Oncol; 2024 Oct; 65(4):. PubMed ID: 39239752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12.
    Chen J; Feng W; Sun M; Huang W; Wang G; Chen X; Yin Y; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L
    Gastroenterology; 2024 Jul; 167(2):264-280. PubMed ID: 38417530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Nanoimmunotherapy by Modulating Tumor-Associated Macrophages for Cancer Therapy.
    Hao J; Zhao X; Wang C; Cao X; Liu Y
    Bioconjug Chem; 2024 Jul; 35(7):867-882. PubMed ID: 38919067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients.
    Tang J; Ming L; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y
    Immunobiology; 2024 May; 229(3):152805. PubMed ID: 38669865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tumor-associated macrophages in hepatocellular carcinoma: impact, mechanism, and therapy.
    Zhang Y; Han G; Gu J; Chen Z; Wu J
    Front Immunol; 2024; 15():1429812. PubMed ID: 39170620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic studies of tumor-associated macrophage immunotherapy.
    Cao J; Liu C
    Front Immunol; 2024; 15():1476565. PubMed ID: 39403370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials.
    Zhang W; Wang M; Ji C; Liu X; Gu B; Dong T
    Biomed Pharmacother; 2024 Aug; 177():116930. PubMed ID: 38878638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering Endogenous Tumor-Associated Macrophage-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy.
    Wang Y; Yu J; Luo Z; Shi Q; Liu G; Wu F; Wang Z; Huang Y; Zhou D
    Adv Mater; 2021 Oct; 33(39):e2103497. PubMed ID: 34387375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer.
    Xiao M; He J; Yin L; Chen X; Zu X; Shen Y
    Front Immunol; 2021; 12():799428. PubMed ID: 34992609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Evasion in Cancer Is Regulated by Tumor-Asociated Macrophages (TAMs): Targeting TAMs.
    Jung M; Bonavida B
    Crit Rev Oncog; 2024; 29(4):1-17. PubMed ID: 38989734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of Hierarchically Biomimetic Iron Oxide Nanosystems for Macrophage Repolarization-Promoted Immune Checkpoint Blockade of Cancer Immunotherapy.
    Kang Y; Yan J; Han X; Wang X; Wang Y; Song P; Su X; Rauf A; Jin X; Pu F; Zhang H
    ACS Appl Mater Interfaces; 2024 Jul; 16(28):36131-36141. PubMed ID: 38979627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
    Mojsilovic SS; Mojsilovic S; Villar VH; Santibanez JF
    Anal Cell Pathol (Amst); 2021; 2021():5523055. PubMed ID: 34476174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
    Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
    Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tumor-associated macrophages in tumor immune evasion.
    Huang R; Kang T; Chen S
    J Cancer Res Clin Oncol; 2024 May; 150(5):238. PubMed ID: 38713256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.